Literature DB >> 20528223

Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.

Deirdre Cronin-Fenton, Timothy L Lash, Henrik T Sørensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528223     DOI: 10.2217/fon.10.65

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  7 in total

Review 1.  Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.

Authors:  Deirdre P Cronin-Fenton; Timothy L Lash
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

Review 2.  Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy.

Authors:  Deirdre P Cronin-Fenton; Per Damkier; Timothy L Lash
Journal:  Future Oncol       Date:  2014-01       Impact factor: 3.404

3.  Existing data sources for clinical epidemiology: Aarhus University Prescription Database.

Authors:  Vera Ehrenstein; Sussie Antonsen; Lars Pedersen
Journal:  Clin Epidemiol       Date:  2010-12-02       Impact factor: 4.790

Review 4.  Depression screening and patient outcomes in cancer: a systematic review.

Authors:  Anna Meijer; Michelle Roseman; Katherine Milette; James C Coyne; Michael E Stefanek; Roy C Ziegelstein; Erin Arthurs; Allison Leavens; Steven C Palmer; Donna E Stewart; Peter de Jonge; Brett D Thombs
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

5.  Fluoxetine modulates breast cancer metastasis to the brain in a murine model.

Authors:  Yuriy Shapovalov; Martha Zettel; Sara C Spielman; Stacy A Amico-Ruvio; Emily A Kelly; Grayson O Sipe; Ian M Dickerson; Ania K Majewska; Edward B Brown
Journal:  BMC Cancer       Date:  2014-08-16       Impact factor: 4.430

6.  The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer - Trial protocol of a phase II study.

Authors:  Fionán Donohoe; Yvonne O'Meara; Aidin Roberts; Louise Comerford; Catherine M Kelly; Janice M Walshe; Michelle Peate; Martha Hickey; Donal J Brennan
Journal:  Contemp Clin Trials Commun       Date:  2021-11-11

Review 7.  The Underrated Risks of Tamoxifen Drug Interactions.

Authors:  Philip D Hansten
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-10       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.